SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-101834"
 

Sökning: id:"swepub:oai:DiVA.org:liu-101834" > Potentiation of bra...

Potentiation of brain stimulation reward by morphine : effects of neurokinin-1 receptor antagonism

Robinson, J. E. (författare)
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Fish, E. W. (författare)
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Krouse, M. C. (författare)
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
visa fler...
Thorsell, Annika (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA
Heilig, Marcus (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA
Malanga, C. J. (författare)
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
visa färre...
 (creator_code:org_t)
2011-09-10
2012
Engelska.
Ingår i: Psychopharmacology. - : Springer. - 0033-3158 .- 1432-2072. ; 220:1, s. 215-224
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • RATIONALE: The abuse potential of opioids may be due to their reinforcing and rewarding effects, which may be attenuated by neurokinin-1 receptor (NK1R) antagonists.OBJECTIVE: This study was conducted to measure the effects of opioid and NK1R blockade on the potentiation of brain stimulation reward (BSR) by morphine using the intracranial self-stimulation method.METHODS: Adult male C57BL/6J mice (n = 15) were implanted with unipolar stimulating electrodes in the lateral hypothalamus and trained to respond for varying frequencies of rewarding electrical stimulation. The BSR threshold (θ(0)) and maximum response rate (MAX) were determined before and after intraperitoneal administration of saline, morphine (1.0-17.0 mg/kg), or the NK1R antagonists L-733,060 (1.0-17.0 mg/kg) and L-703,606 (1.0-17.0 mg/kg). In morphine antagonism experiments, naltrexone (0.1-1.0 mg/kg) or 10.0 mg/kg L-733,060 or L-703,606 was administered 15 min before morphine (1.0-10.0 mg/kg) or saline.RESULTS: Morphine dose-dependently decreased θ(0) (maximum effect = 62% of baseline) and altered MAX when compared to saline. L-703,606 and L-733,060 altered θ(0); 10.0 mg/kg L-733,060 and L-703,606, which did not affect θ(0) or MAX, attenuated the effects of 3.0 and 10.0 mg/kg morphine, and 1.0 and 0.3 mg/kg naltrexone blocked the effects of 10.0 mg/kg morphine. Naltrexone given before saline did not affect θ(0) or MAX.CONCLUSIONS: The decrease in θ(0) by morphine reflects its rewarding effects, which were attenuated by NK1R and opioid receptor blockade. These results demonstrate the importance of substance P signaling during limbic reward system activation by opioids.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Morphine
Opioid
Neurokinin
Substance P
Dopamine
Reward
Reinforcement

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy